Response to letter – Androgen deprivation therapy and cardiovascular risk: No meaningful difference between GnRH antagonist and agonists - Université de Rennes Access content directly
Journal Articles European Journal of Cancer Year : 2017

Response to letter – Androgen deprivation therapy and cardiovascular risk: No meaningful difference between GnRH antagonist and agonists

Fichier principal
Vignette du fichier
Response to_Androgen deprivation therapy .pdf (178.74 Ko) Télécharger le fichier
Origin : Files produced by the author(s)

Dates and versions

hal-01661110 , version 1 (11-12-2017)

Identifiers

Cite

Lucie-Marie Scailteux. Response to letter – Androgen deprivation therapy and cardiovascular risk: No meaningful difference between GnRH antagonist and agonists. European Journal of Cancer, 2017, 87, pp.204. ⟨10.1016/j.ejca.2017.06.042⟩. ⟨hal-01661110⟩
122 View
196 Download

Altmetric

Share

Gmail Facebook X LinkedIn More